Total Payments
$2,742
2024 Payments
$1,458
Companies
16
Transactions
92
Medicare Patients
302
Medicare Billing
$39,281

Payment Breakdown by Category

Food & Beverage$2,489 (90.8%)
Education$253.05 (9.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,489 91 90.8%
Education $253.05 1 9.2%

Top Paying Companies

Company Total Records Latest Year
Abbott Laboratories $646.20 7 $0 (2023)
Novartis Pharmaceuticals Corporation $353.62 22 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $335.35 5 $0 (2024)
AstraZeneca Pharmaceuticals LP $225.28 13 $0 (2024)
E.R. Squibb & Sons, L.L.C. $207.28 10 $0 (2024)
PFIZER INC. $163.92 7 $0 (2024)
ShockWave Medical, Inc $153.56 1 $0 (2024)
Amgen Inc. $139.43 5 $0 (2024)
Esperion Therapeutics, Inc. $115.51 5 $0 (2024)
Merck Sharp & Dohme LLC $104.98 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,458 66 Novartis Pharmaceuticals Corporation ($337.63)
2023 $537.17 19 Abbott Laboratories ($162.91)
2022 $460.18 3 Abbott Laboratories ($460.18)
2021 $268.24 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($245.13)
2018 $19.24 1 GlaxoSmithKline, LLC. ($19.24)

All Payment Transactions

92 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/20/2024 AstraZeneca Pharmaceuticals LP WAINUA (Drug) Food and Beverage In-kind items and services $14.12 General
Category: Cardiovascular and Metabolism
12/17/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $21.00 General
Category: CARDIOVASCULAR
12/11/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $22.52 General
Category: Cardiology
12/10/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.31 General
Category: Cardio-renal
11/22/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.33 General
Category: Cardiology/Vascular Diseases
11/20/2024 ShockWave Medical, Inc Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) Food and Beverage In-kind items and services $153.56 General
Category: Lithoplasty
11/20/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.86 General
Category: Cardiovascular and Metabolism
11/14/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $22.05 General
Category: Cardiovascular
11/12/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $23.64 General
Category: ANTILIPEMIC AGENTS
11/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $31.82 General
Category: DIABETES
11/01/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $26.58 General
Category: Cardiology/Vascular Diseases
10/16/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $29.77 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/16/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $24.98 General
Category: ANTILIPEMIC AGENTS
10/10/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.18 General
Category: Cardiology/Vascular Diseases
10/02/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.37 General
Category: Cardiovascular
09/27/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $29.00 General
Category: Cardiology/Vascular Diseases
09/26/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $21.97 General
Category: CARDIOVASCULAR
09/20/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $29.78 General
Category: Cardio-renal
09/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $26.71 General
Category: Cardiology
09/19/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $8.21 General
Category: Cardiovascular
09/17/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $23.15 General
Category: Cardiology/Vascular Diseases
09/05/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.90 General
Category: Cardiovascular and Metabolism
08/15/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $15.13 General
Category: Cardiology/Vascular Diseases
08/15/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $2.38 General
Category: Cardiology/Vascular Diseases
08/09/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $27.94 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 137 179 $148,983 $16,924
2022 3 130 191 $125,654 $16,832
2021 1 35 57 $42,243 $5,526
Total Patients
302
Total Services
427
Medicare Billing
$39,281
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 24 53 $35,618 $5,757 16.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 41 47 $29,245 $4,923 16.8%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 18 18 $54,450 $3,123 5.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 14 16 $17,520 $2,532 14.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 40 45 $12,150 $588.36 4.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 89 135 $97,554 $13,054 13.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 30 45 $22,512 $3,024 13.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 11 11 $5,588 $754.00 13.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 35 57 $42,243 $5,526 13.1%

About Dr. Mohammed Algodi, M.D

Dr. Mohammed Algodi, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760839450.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Algodi, M.D has received a total of $2,742 in payments from pharmaceutical and medical device companies, with $1,458 received in 2024. These payments were reported across 92 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,489).

As a Medicare-enrolled provider, Algodi has provided services to 302 Medicare beneficiaries, totaling 427 services with total Medicare billing of $39,281. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.

Practice Information

Products in Payments

  • JARDIANCE (Drug) $335.35
  • MITRACLIP (Device) $332.56
  • THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $290.53
  • ELIQUIS (Drug) $259.24
  • LEQVIO (Drug) $231.32
  • FARXIGA (Drug) $193.61
  • Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $153.56
  • Repatha (Biological) $139.43
  • ENTRESTO (Drug) $122.30
  • NEXLETOL (Drug) $115.51
  • VERQUVO (Drug) $104.98
  • Kerendia (Drug) $103.83
  • Ozempic (Drug) $77.67
  • CAMZYOS (Drug) $71.85
  • SAPIEN 3 Ultra RESILIA (Device) $47.21
  • VYNDAQEL (Drug) $40.11
  • MULTAQ (Drug) $26.90
  • Confirm Rx (Device) $23.11
  • Inpefa (Drug) $22.49
  • SHINGRIX (Biological) $19.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx